Shares of NutriSystem Inc (NASDAQ:NTRI) have received an average recommendation of “Buy” from the ten ratings firms that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $68.11.

Several equities research analysts have recently commented on NTRI shares. Craig Hallum set a $70.00 price target on NutriSystem and gave the stock a “buy” rating in a research note on Tuesday, July 18th. BidaskClub upgraded NutriSystem from a “hold” rating to a “buy” rating in a research report on Wednesday, August 9th. DA Davidson restated a “buy” rating and set a $64.00 price objective on shares of NutriSystem in a research report on Monday, July 24th. Zacks Investment Research upgraded NutriSystem from a “hold” rating to a “strong-buy” rating and set a $64.00 price objective for the company in a research report on Saturday, July 29th. Finally, Sidoti upgraded NutriSystem from a “neutral” rating to a “buy” rating and set a $60.00 price objective for the company in a research report on Monday, June 12th.

In other news, insider Dawn M. Zier sold 29,100 shares of the business’s stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $54.00, for a total transaction of $1,571,400.00. Following the completion of the sale, the insider now directly owns 273,867 shares of the company’s stock, valued at approximately $14,788,818. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Robert F. Bernstock sold 7,000 shares of the business’s stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $53.26, for a total transaction of $372,820.00. Following the sale, the director now directly owns 25,350 shares of the company’s stock, valued at $1,350,141. The disclosure for this sale can be found here. Insiders have sold a total of 106,221 shares of company stock valued at $5,633,245 over the last three months. Corporate insiders own 2.40% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Alps Advisors Inc. grew its stake in shares of NutriSystem by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 9,812 shares of the company’s stock valued at $511,000 after buying an additional 25 shares during the period. Pinebridge Investments L.P. boosted its position in NutriSystem by 1.1% during the 2nd quarter. Pinebridge Investments L.P. now owns 3,939 shares of the company’s stock worth $205,000 after purchasing an additional 41 shares during the period. US Bancorp DE boosted its position in NutriSystem by 2.2% during the 1st quarter. US Bancorp DE now owns 5,211 shares of the company’s stock worth $289,000 after purchasing an additional 110 shares during the period. Creative Planning boosted its position in NutriSystem by 5.3% during the 2nd quarter. Creative Planning now owns 3,377 shares of the company’s stock worth $176,000 after purchasing an additional 171 shares during the period. Finally, Texas Permanent School Fund boosted its position in NutriSystem by 0.9% during the 2nd quarter. Texas Permanent School Fund now owns 21,832 shares of the company’s stock worth $1,136,000 after purchasing an additional 199 shares during the period. 92.59% of the stock is owned by institutional investors.

Shares of NutriSystem (NASDAQ NTRI) traded up 1.83% during trading on Wednesday, hitting $53.00. The company’s stock had a trading volume of 341,223 shares. The company has a 50-day moving average price of $53.23 and a 200-day moving average price of $52.80. NutriSystem has a one year low of $28.72 and a one year high of $67.95. The stock has a market cap of $1.58 billion, a PE ratio of 32.84 and a beta of 1.15.

NutriSystem (NASDAQ:NTRI) last announced its quarterly earnings results on Wednesday, July 26th. The company reported $0.80 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.62 by $0.18. The business had revenue of $194.90 million for the quarter, compared to analyst estimates of $180.75 million. NutriSystem had a return on equity of 48.41% and a net margin of 7.60%. The company’s quarterly revenue was up 30.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.54 EPS. Equities analysts predict that NutriSystem will post $1.91 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Daily Political and is the property of of Daily Political. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.dailypolitical.com/2017/09/23/nutrisystem-inc-ntri-receives-68-11-consensus-target-price-from-analysts.html.

About NutriSystem

Nutrisystem, Inc is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company’s program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy.

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem Inc and related companies with MarketBeat.com's FREE daily email newsletter.